You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Drug Formulary
About the Drug Formulary Email Drug Formulary Team

riTUXimab

Pronunciation: rit-TUCKS-ee-mab
Other Name(s): Rituxan®; Truxima™; Riximyo™; Ruxience™; Riabni™
Appearance: Clear, colourless solution mixed into larger bags of fluids

Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.

Drug Monograph

Oct 2023
Table of Contents
Eligibility Forms
pdf download Rituximab (Biosimilar IV) - Single Agent - Indolent Lymphoma pdf download Rituximab (Biosimilar IV) and Rituximab SC - Aggressive Histology Lymphoma pdf download Rituximab (Biosimilar IV) and Rituximab SC - HIV-Related Aggressive Histology B-cell Lymphoma pdf download Rituximab (Biosimilar IV) and Rituximab SC - Maintenance Treatment - Lymphoma pdf download Rituximab (Biosimilar IV) and Rituximab SC - Previously Untreated Chronic Lymphocytic Leukemia pdf download Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Indolent Lymphoma pdf download Rituximab (Biosimilar IV) and Rituximab SC - Second Line - Chronic Lymphocytic Leukemia pdf download Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Aggressive Histology Lymphoma pdf download Rituximab (Biosimilar IV) - In Combination with Idelalisib - Relapsed Chronic Lymphocytic Leukemia pdf download Rituximab (Biosimilar IV) and Rituximab SC - In Combination with Venetoclax - Relapsed Chronic Lymphocytic Leukemia pdf download Polatuzumab Vedotin with Bendamustine and Rituximab (Biosimilar) - Relapsed or Refractory Diffuse Large B-cell Lymphoma pdf download Rituximab (Biosimilar IV) - As Part of the MATRix Regimen in Newly Diagnosed Previously Untreated PCNSL pdf download Rituximab (Biosimilar IV) and Rituximab SC in Combination with Chemotherapy - Indolent B-cell Lymphoma

Patient Info Sheet

Oct 2023

What it is used for

  • For treating blood cancers such as non-Hodgkin's lymphoma or chronic lymphocytic leukemia (CLL) 
  • Rituximab is available as a biosimilar medication. See our biosimilar pamphlet for more information. 


You might also be interested in

Funding & Reimbursement

Several payment sources exist for cancer drugs in Ontario, depending on the drug, disease indication, and how and where it is delivered.

View Funding & Reimbursement

Symptom Management

Many people living with cancer experience nausea, diarrhea and other symptoms from their treatment or disease.

View Symptom Management

Drug Safety and Administration

Find documents on drug safety and administration for healthcare providers, including calculations and recommendations.

View Drug Safety and Administration